The C11orf68 Knockout HEK293T Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the C11orf68 gene has been disrupted via non-homologous end joining (NHEJ) following Cas9-induced double-strand breaks. This product provides a heterogeneous pool of HEK293T cells carrying diverse loss-of-function mutations across the target locus, enabling robust functional studies without the clonal biases inherent to single-cell-derived lines. The polyclonal format is particularly suited for pooled screening approaches and assays requiring population-level phenotypic averaging, offering a cost-effective and statistically powered tool for initial gene characterization.
Derived from the widely utilized HEK293T cell line, the host cells are human embryonic kidney epithelial cells that stably express the SV40 large T antigen, a feature that enhances episomal replication of plasmids containing the SV40 origin of replication. This background confers exceptionally high transfection efficiency and high-level protein expression, making HEK293T a cornerstone model for recombinant protein production, viral packaging, and transient overexpression studies. Consequently, the knockout cells retain the parental line??s amenability to transient and stable genetic manipulation, facilitating complementation experiments, rescue assays, and the introduction of tagged constructs for downstream analyses.
The C11orf68 gene encodes a predicted transmembrane protein of unknown function, with bioinformatic analyses indicating multiple transmembrane domains but no assigned catalytic activity or known interacting partners. While its biological role remains poorly characterized, preliminary studies and database annotations suggest a potential involvement in cell proliferation, though direct evidence is lacking. The knockout model serves as a critical reagent for dissecting C11orf68??s molecular interactions, as the polyclonal disruption enables investigators to probe phenotypic consequences and identify associated proteins through techniques such as co-immunoprecipitation and mass spectrometry-based proteomics, without the confounding effects of a uniform genetic lesion.
In the HEK293T context, loss of C11orf68 is expected to perturb proliferation dynamics, apoptosis susceptibility, or cell cycle progression if the protein plays a functional role in these processes. The epithelial origin and easy scalability of HEK293T cells make the knockout pool ideal for high-throughput proliferation and viability assays, as well as for genome-wide CRISPR modifier screens to uncover genetic interactions. Moreover, the cells can be adapted to three-dimensional culture or co-culture systems to assess C11orf68??s role in cell?Ccell contacts or matrix attachment, leveraging the host cell??s robust growth characteristics.
Key applications include functional characterization through proliferation and apoptosis assays, transcriptomic profiling by RNA-seq, proteomic analyses to catalog interacting partners, and immunofluorescence-based localization studies. The knockout cells are also suitable for co-immunoprecipitation to validate candidate interactors and for biomarker validation studies in cancer biology contexts, given C11orf68??s potential link to proliferation control. For further information or to explore custom applications, please contact Ascent Research.
